Latest News

• share
• favorite_border

A new study from researchers at USC suggests that having a dog in the home may worsen the response to air pollution of a child with asthma.

• share
• favorite_border

About half of women whose breast cancer is treated with standard chemotherapy have their cancer return within five years. Most chemotherapeutic drugs have undesirable side effects, but there has been no way to predict who would benefit and who wouldn't. Fortunately, new research findings at the University of Southern California could change that.

• share
• favorite_border

A new study of twins suggests that living farther north of the equator significantly increases risk of developing Multiple Sclerosis (MS) among those with genetic susceptibility due to some environmental factor.

• share
• favorite_border

Teens at risk of developing diabetes can prevent or delay its onset through strength training exercise, a University of Southern California study has found.

• share
• favorite_border

A protein that allows breast cancer cells to evade the body's natural immune responses could be a target of future cancer therapies, according to a study by Keck School of Medicine of USC scientists published today.

• share
• favorite_border

Researchers have long known that reasons for smoking include social pressure and other environmental factors, as well as genetic factors based on results of previous twin studies. Now a more comprehensive study of twins by researchers at USC has provided a better understanding of these complex influences. They found that women are far more likely than men to start smoking because of environmental factors.

• share
• favorite_border

A new test can help determine whether a prostate cancer patient will go on to have a recurrence of the disease.

• share
• favorite_border

Scientists report that tumor cells display a dramatic reduction of cancer-causing genes when a newly discovered method is used to activate the expression of protective microRNAs in the cancer cell genome. The research demonstrates that agents known to regulate gene expression can also impact regulatory RNAs that may function as tumor suppressors in normal cells and proposes a novel strategy for treating human cancers.

• share
• favorite_border

Children living near major roadways are more likely to have asthma than those just a few blocks away according to a new Univ. of Southern California study.

• share
• favorite_border

Keck School of Medicine of USC announces it receives first funding for stem cell training grant from CA Institute for Regenerative Medicine.

• share
• favorite_border

Gift to support construction of new 215,000 sq. foot facility - largest stem cell research facility in California.

• share
• favorite_border

Two variations in the gene for insulin-like growth factor I (IGF-1) are linked to an increased risk of prostate cancer, according to research.

• share
• favorite_border

Martin F. Pera, an internationally renowned expert in the development of human embryonic stem cells and the control of growth and differentiation of human pluripotent stem cells, has been named director of the newly created Institute for Stem Cell and Regenerative Medicine (ISCRM) at USC.

• share
• favorite_border

Research may lead to insight on human organ regeneration. The stem cells that produce bird feathers have been visualized and analyzed for the first time, signifying the initial step in a scientific journey that may ultimately shed light on human organ regeneration.

• share
• favorite_border

USC-led study shows significant death risk linked to airborne particles.

• share
• favorite_border

USC investigators show proximity to freeways poses respiratory risk.

• share
• favorite_border

According to a USC study, popular students in 16 Southern California middle schools were more likely to become smokers than their less popular peers.

• share
• favorite_border

A Second Grant Awarded to University of Southern California-Affiliated Childrens Hospital Los Angeles Makes USC Top Funded Medical School in CA.

• share
• favorite_border

A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies.

• share
• favorite_border

Cancer cells may be able to avoid destruction by anti-vascular and anti-angiogenesis agents through a cellular stress response that activates a pro-survival protein called GRP78.